Teva Pharmaceutical Industries Income After Taxes 2010-2024 | TEVA
Teva Pharmaceutical Industries income after taxes for the twelve months ending September 30, 2024 was $-1.217B, a 49.92% decline year-over-year.
- Teva Pharmaceutical Industries annual income after taxes for 2023 was $-0.617B, a 75.52% decline from 2022.
- Teva Pharmaceutical Industries annual income after taxes for 2022 was $-2.52B, a 663.76% decline from 2021.
- Teva Pharmaceutical Industries annual income after taxes for 2021 was $0.447B, a 110.55% decline from 2020.